Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Orphanet Journal of Rare Diseases
Published in: Orphanet Journal of Rare Diseases 1/2015

Open Access 01-12-2015 | Letter to the Editor

Rare diseases and orphan drugs: 500 years ago

Author: Marc M. Dooms

Published in: Orphanet Journal of Rare Diseases | Issue 1/2015

Login to get access

Abstract

In 1581 Rembert Dodoens wrote “Medicinalium observationum exempla rara, recognita et aucta” a Latin book about the diagnosis and treatment of disorders with a low prevalence.
Literature
1.
Covey HC. People with Leprosy (Hansen’s Disease) during the Middle Ages. The Social Science Journal. 2001;38:315–21.CrossRef
2.
3.
4.
Fossier R. The Cambridge Illustrated History of the Middle Ages. 3: 1250–1520. Cambridge: University Press; 1998.
5.
Koenigsberger HG, Mosse GL, Bowler GQ. Europe in the Sixteenth Century. London – New York: Longman; 1989.
6.
Louis A. La vie et l’oeuvre botanique de Rembert Dodoens (1517–1585). Gembloux: Ducolot; 1950.
7.
Porter R. The Cambridge History of Medicine. Cambridge: University Press; 2006.
Metadata
Title
Rare diseases and orphan drugs: 500 years ago
Author
Marc M. Dooms
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Orphanet Journal of Rare Diseases / Issue 1/2015
Electronic ISSN: 1750-1172
DOI
https://doi.org/10.1186/s13023-015-0353-3

Other articles of this Issue 1/2015

Orphanet Journal of Rare Diseases 1/2015 Go to the issue

Letter to the Editor

Large exonic deletions in POLRB gene cause POLR3-related leukodystrophy

Letter to the Editor

High prevalence of hyposalivation in individuals with neurofibromatosis 1: a case–control study

Research

The spectrum of KIAA0196 variants, and characterization of a murine knockout: implications for the mutational mechanism in hereditary spastic paraplegia type SPG8

Research

CMTX1 patients’ cells present genomic instability corrected by CamKII inhibitors

Review

Immunosuppressive drugs and fertility

Research

Neutrophil activation during attacks in patients with hereditary angioedema due to C1-inhibitor deficiency